ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Diphtheria Tetanus Pertussis Vaccine Market Research Report 2025
Published Date: January 2025
|
Report Code: QYRE-Auto-39C13395
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Diphtheria Tetanus Pertussis Vaccine Market Research Report 2023
BUY CHAPTERS

Global Diphtheria Tetanus Pertussis Vaccine Market Research Report 2025

Code: QYRE-Auto-39C13395
Report
January 2025
Pages:91
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Sanofi Pasteur
GSK
AJ Vaccines
KM Biologics (Meiji)
MCM Vaccine
Merck
MassBiologics
Bionet-Asia
Amson Vaccines & Pharma
Serum Institute of India
Panacea Biotec
Biokangtai
China National Biotec
Chengdu Oulin Biological Science&Technology

Diphtheria Tetanus Pertussis Vaccine Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Diphtheria Tetanus Pertussis Vaccine Market

Diphtheria Tetanus Pertussis Vaccine Market

The global market for Diphtheria Tetanus Pertussis Vaccine was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The DPT vaccine or DTP vaccine is a class of combination vaccines against three infectious diseases in humans: diphtheria, pertussis (whooping cough), and tetanus.The vaccine components include diphtheria and tetanus toxoids and either killed whole cells of the bacterium that causes pertussis or pertussis antigens.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Diphtheria Tetanus Pertussis Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Diphtheria Tetanus Pertussis Vaccine.
The Diphtheria Tetanus Pertussis Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Diphtheria Tetanus Pertussis Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Diphtheria Tetanus Pertussis Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Diphtheria Tetanus Pertussis Vaccine Market Report

Report Metric Details
Report Name Diphtheria Tetanus Pertussis Vaccine Market
CAGR 5%
Segment by Type
  • DTwP Type
  • DTaP Type
Segment by Application
  • Child
  • Teenager
  • Aldult
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Sanofi Pasteur, GSK, AJ Vaccines, KM Biologics (Meiji), MCM Vaccine, Merck, MassBiologics, Bionet-Asia, Amson Vaccines & Pharma, Serum Institute of India, Panacea Biotec, BioKangtai, China National Biotec, Chengdu Oulin Biological Science&Technology
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Diphtheria Tetanus Pertussis Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Diphtheria Tetanus Pertussis Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Diphtheria Tetanus Pertussis Vaccine Market report?

Ans: The main players in the Diphtheria Tetanus Pertussis Vaccine Market are Sanofi Pasteur, GSK, AJ Vaccines, KM Biologics (Meiji), MCM Vaccine, Merck, MassBiologics, Bionet-Asia, Amson Vaccines & Pharma, Serum Institute of India, Panacea Biotec, BioKangtai, China National Biotec, Chengdu Oulin Biological Science&Technology

What are the Application segmentation covered in the Diphtheria Tetanus Pertussis Vaccine Market report?

Ans: The Applications covered in the Diphtheria Tetanus Pertussis Vaccine Market report are Child, Teenager, Aldult

What are the Type segmentation covered in the Diphtheria Tetanus Pertussis Vaccine Market report?

Ans: The Types covered in the Diphtheria Tetanus Pertussis Vaccine Market report are DTwP Type, DTaP Type

Recommended Reports

DTP/DTPa Vaccines

Pediatric Vaccines

Vaccine Market Overview

1 Diphtheria Tetanus Pertussis Vaccine Market Overview
1.1 Product Definition
1.2 Diphtheria Tetanus Pertussis Vaccine by Type
1.2.1 Global Diphtheria Tetanus Pertussis Vaccine Market Value Comparison by Type (2024 VS 2031)
1.2.2 DTwP Type
1.2.3 DTaP Type
1.3 Diphtheria Tetanus Pertussis Vaccine by Application
1.3.1 Global Diphtheria Tetanus Pertussis Vaccine Market Value by Application (2024 VS 2031)
1.3.2 Child
1.3.3 Teenager
1.3.4 Aldult
1.4 Global Diphtheria Tetanus Pertussis Vaccine Market Size Estimates and Forecasts
1.4.1 Global Diphtheria Tetanus Pertussis Vaccine Revenue 2020-2031
1.4.2 Global Diphtheria Tetanus Pertussis Vaccine Sales 2020-2031
1.4.3 Global Diphtheria Tetanus Pertussis Vaccine Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Diphtheria Tetanus Pertussis Vaccine Market Competition by Manufacturers
2.1 Global Diphtheria Tetanus Pertussis Vaccine Sales Market Share by Manufacturers (2020-2025)
2.2 Global Diphtheria Tetanus Pertussis Vaccine Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Diphtheria Tetanus Pertussis Vaccine Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Diphtheria Tetanus Pertussis Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Diphtheria Tetanus Pertussis Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Diphtheria Tetanus Pertussis Vaccine, Product Type & Application
2.7 Global Key Manufacturers of Diphtheria Tetanus Pertussis Vaccine, Date of Enter into This Industry
2.8 Global Diphtheria Tetanus Pertussis Vaccine Market Competitive Situation and Trends
2.8.1 Global Diphtheria Tetanus Pertussis Vaccine Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Diphtheria Tetanus Pertussis Vaccine Players Market Share by Revenue
2.8.3 Global Diphtheria Tetanus Pertussis Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Diphtheria Tetanus Pertussis Vaccine Market Scenario by Region
3.1 Global Diphtheria Tetanus Pertussis Vaccine Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Diphtheria Tetanus Pertussis Vaccine Sales by Region: 2020-2031
3.2.1 Global Diphtheria Tetanus Pertussis Vaccine Sales by Region: 2020-2025
3.2.2 Global Diphtheria Tetanus Pertussis Vaccine Sales by Region: 2026-2031
3.3 Global Diphtheria Tetanus Pertussis Vaccine Revenue by Region: 2020-2031
3.3.1 Global Diphtheria Tetanus Pertussis Vaccine Revenue by Region: 2020-2025
3.3.2 Global Diphtheria Tetanus Pertussis Vaccine Revenue by Region: 2026-2031
3.4 North America Diphtheria Tetanus Pertussis Vaccine Market Facts & Figures by Country
3.4.1 North America Diphtheria Tetanus Pertussis Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Diphtheria Tetanus Pertussis Vaccine Sales by Country (2020-2031)
3.4.3 North America Diphtheria Tetanus Pertussis Vaccine Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Diphtheria Tetanus Pertussis Vaccine Market Facts & Figures by Country
3.5.1 Europe Diphtheria Tetanus Pertussis Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Diphtheria Tetanus Pertussis Vaccine Sales by Country (2020-2031)
3.5.3 Europe Diphtheria Tetanus Pertussis Vaccine Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Diphtheria Tetanus Pertussis Vaccine Market Facts & Figures by Region
3.6.1 Asia Pacific Diphtheria Tetanus Pertussis Vaccine Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Diphtheria Tetanus Pertussis Vaccine Sales by Region (2020-2031)
3.6.3 Asia Pacific Diphtheria Tetanus Pertussis Vaccine Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Diphtheria Tetanus Pertussis Vaccine Market Facts & Figures by Country
3.7.1 Latin America Diphtheria Tetanus Pertussis Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Diphtheria Tetanus Pertussis Vaccine Sales by Country (2020-2031)
3.7.3 Latin America Diphtheria Tetanus Pertussis Vaccine Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Diphtheria Tetanus Pertussis Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Diphtheria Tetanus Pertussis Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Diphtheria Tetanus Pertussis Vaccine Sales by Country (2020-2031)
3.8.3 Middle East and Africa Diphtheria Tetanus Pertussis Vaccine Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Diphtheria Tetanus Pertussis Vaccine Sales by Type (2020-2031)
4.1.1 Global Diphtheria Tetanus Pertussis Vaccine Sales by Type (2020-2025)
4.1.2 Global Diphtheria Tetanus Pertussis Vaccine Sales by Type (2026-2031)
4.1.3 Global Diphtheria Tetanus Pertussis Vaccine Sales Market Share by Type (2020-2031)
4.2 Global Diphtheria Tetanus Pertussis Vaccine Revenue by Type (2020-2031)
4.2.1 Global Diphtheria Tetanus Pertussis Vaccine Revenue by Type (2020-2025)
4.2.2 Global Diphtheria Tetanus Pertussis Vaccine Revenue by Type (2026-2031)
4.2.3 Global Diphtheria Tetanus Pertussis Vaccine Revenue Market Share by Type (2020-2031)
4.3 Global Diphtheria Tetanus Pertussis Vaccine Price by Type (2020-2031)
5 Segment by Application
5.1 Global Diphtheria Tetanus Pertussis Vaccine Sales by Application (2020-2031)
5.1.1 Global Diphtheria Tetanus Pertussis Vaccine Sales by Application (2020-2025)
5.1.2 Global Diphtheria Tetanus Pertussis Vaccine Sales by Application (2026-2031)
5.1.3 Global Diphtheria Tetanus Pertussis Vaccine Sales Market Share by Application (2020-2031)
5.2 Global Diphtheria Tetanus Pertussis Vaccine Revenue by Application (2020-2031)
5.2.1 Global Diphtheria Tetanus Pertussis Vaccine Revenue by Application (2020-2025)
5.2.2 Global Diphtheria Tetanus Pertussis Vaccine Revenue by Application (2026-2031)
5.2.3 Global Diphtheria Tetanus Pertussis Vaccine Revenue Market Share by Application (2020-2031)
5.3 Global Diphtheria Tetanus Pertussis Vaccine Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Sanofi Pasteur
6.1.1 Sanofi Pasteur Company Information
6.1.2 Sanofi Pasteur Description and Business Overview
6.1.3 Sanofi Pasteur Diphtheria Tetanus Pertussis Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Sanofi Pasteur Diphtheria Tetanus Pertussis Vaccine Product Portfolio
6.1.5 Sanofi Pasteur Recent Developments/Updates
6.2 GSK
6.2.1 GSK Company Information
6.2.2 GSK Description and Business Overview
6.2.3 GSK Diphtheria Tetanus Pertussis Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.2.4 GSK Diphtheria Tetanus Pertussis Vaccine Product Portfolio
6.2.5 GSK Recent Developments/Updates
6.3 AJ Vaccines
6.3.1 AJ Vaccines Company Information
6.3.2 AJ Vaccines Description and Business Overview
6.3.3 AJ Vaccines Diphtheria Tetanus Pertussis Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.3.4 AJ Vaccines Diphtheria Tetanus Pertussis Vaccine Product Portfolio
6.3.5 AJ Vaccines Recent Developments/Updates
6.4 KM Biologics (Meiji)
6.4.1 KM Biologics (Meiji) Company Information
6.4.2 KM Biologics (Meiji) Description and Business Overview
6.4.3 KM Biologics (Meiji) Diphtheria Tetanus Pertussis Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.4.4 KM Biologics (Meiji) Diphtheria Tetanus Pertussis Vaccine Product Portfolio
6.4.5 KM Biologics (Meiji) Recent Developments/Updates
6.5 MCM Vaccine
6.5.1 MCM Vaccine Company Information
6.5.2 MCM Vaccine Description and Business Overview
6.5.3 MCM Vaccine Diphtheria Tetanus Pertussis Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.5.4 MCM Vaccine Diphtheria Tetanus Pertussis Vaccine Product Portfolio
6.5.5 MCM Vaccine Recent Developments/Updates
6.6 Merck
6.6.1 Merck Company Information
6.6.2 Merck Description and Business Overview
6.6.3 Merck Diphtheria Tetanus Pertussis Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Merck Diphtheria Tetanus Pertussis Vaccine Product Portfolio
6.6.5 Merck Recent Developments/Updates
6.7 MassBiologics
6.7.1 MassBiologics Company Information
6.7.2 MassBiologics Description and Business Overview
6.7.3 MassBiologics Diphtheria Tetanus Pertussis Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.7.4 MassBiologics Diphtheria Tetanus Pertussis Vaccine Product Portfolio
6.7.5 MassBiologics Recent Developments/Updates
6.8 Bionet-Asia
6.8.1 Bionet-Asia Company Information
6.8.2 Bionet-Asia Description and Business Overview
6.8.3 Bionet-Asia Diphtheria Tetanus Pertussis Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Bionet-Asia Diphtheria Tetanus Pertussis Vaccine Product Portfolio
6.8.5 Bionet-Asia Recent Developments/Updates
6.9 Amson Vaccines & Pharma
6.9.1 Amson Vaccines & Pharma Company Information
6.9.2 Amson Vaccines & Pharma Description and Business Overview
6.9.3 Amson Vaccines & Pharma Diphtheria Tetanus Pertussis Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Amson Vaccines & Pharma Diphtheria Tetanus Pertussis Vaccine Product Portfolio
6.9.5 Amson Vaccines & Pharma Recent Developments/Updates
6.10 Serum Institute of India
6.10.1 Serum Institute of India Company Information
6.10.2 Serum Institute of India Description and Business Overview
6.10.3 Serum Institute of India Diphtheria Tetanus Pertussis Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Serum Institute of India Diphtheria Tetanus Pertussis Vaccine Product Portfolio
6.10.5 Serum Institute of India Recent Developments/Updates
6.11 Panacea Biotec
6.11.1 Panacea Biotec Company Information
6.11.2 Panacea Biotec Description and Business Overview
6.11.3 Panacea Biotec Diphtheria Tetanus Pertussis Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Panacea Biotec Diphtheria Tetanus Pertussis Vaccine Product Portfolio
6.11.5 Panacea Biotec Recent Developments/Updates
6.12 BioKangtai
6.12.1 BioKangtai Company Information
6.12.2 BioKangtai Description and Business Overview
6.12.3 BioKangtai Diphtheria Tetanus Pertussis Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.12.4 BioKangtai Diphtheria Tetanus Pertussis Vaccine Product Portfolio
6.12.5 BioKangtai Recent Developments/Updates
6.13 China National Biotec
6.13.1 China National Biotec Company Information
6.13.2 China National Biotec Description and Business Overview
6.13.3 China National Biotec Diphtheria Tetanus Pertussis Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.13.4 China National Biotec Diphtheria Tetanus Pertussis Vaccine Product Portfolio
6.13.5 China National Biotec Recent Developments/Updates
6.14 Chengdu Oulin Biological Science&Technology
6.14.1 Chengdu Oulin Biological Science&Technology Company Information
6.14.2 Chengdu Oulin Biological Science&Technology Description and Business Overview
6.14.3 Chengdu Oulin Biological Science&Technology Diphtheria Tetanus Pertussis Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Chengdu Oulin Biological Science&Technology Diphtheria Tetanus Pertussis Vaccine Product Portfolio
6.14.5 Chengdu Oulin Biological Science&Technology Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Diphtheria Tetanus Pertussis Vaccine Industry Chain Analysis
7.2 Diphtheria Tetanus Pertussis Vaccine Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Diphtheria Tetanus Pertussis Vaccine Production Mode & Process Analysis
7.4 Diphtheria Tetanus Pertussis Vaccine Sales and Marketing
7.4.1 Diphtheria Tetanus Pertussis Vaccine Sales Channels
7.4.2 Diphtheria Tetanus Pertussis Vaccine Distributors
7.5 Diphtheria Tetanus Pertussis Vaccine Customer Analysis
8 Diphtheria Tetanus Pertussis Vaccine Market Dynamics
8.1 Diphtheria Tetanus Pertussis Vaccine Industry Trends
8.2 Diphtheria Tetanus Pertussis Vaccine Market Drivers
8.3 Diphtheria Tetanus Pertussis Vaccine Market Challenges
8.4 Diphtheria Tetanus Pertussis Vaccine Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Sanofi Pasteur
GSK
AJ Vaccines
KM Biologics (Meiji)
MCM Vaccine
Merck
MassBiologics
Bionet-Asia
Amson Vaccines & Pharma
Serum Institute of India
Panacea Biotec
Biokangtai
China National Biotec
Chengdu Oulin Biological Science&Technology
List of Tables
 Table 1. Global Diphtheria Tetanus Pertussis Vaccine Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Diphtheria Tetanus Pertussis Vaccine Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Diphtheria Tetanus Pertussis Vaccine Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Diphtheria Tetanus Pertussis Vaccine Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Diphtheria Tetanus Pertussis Vaccine Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Diphtheria Tetanus Pertussis Vaccine Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Diphtheria Tetanus Pertussis Vaccine Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Diphtheria Tetanus Pertussis Vaccine Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Diphtheria Tetanus Pertussis Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Diphtheria Tetanus Pertussis Vaccine, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Diphtheria Tetanus Pertussis Vaccine, Product Type & Application
 Table 12. Global Key Manufacturers of Diphtheria Tetanus Pertussis Vaccine, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Diphtheria Tetanus Pertussis Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diphtheria Tetanus Pertussis Vaccine as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Diphtheria Tetanus Pertussis Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Diphtheria Tetanus Pertussis Vaccine Sales by Region (2020-2025) & (K Units)
 Table 18. Global Diphtheria Tetanus Pertussis Vaccine Sales Market Share by Region (2020-2025)
 Table 19. Global Diphtheria Tetanus Pertussis Vaccine Sales by Region (2026-2031) & (K Units)
 Table 20. Global Diphtheria Tetanus Pertussis Vaccine Sales Market Share by Region (2026-2031)
 Table 21. Global Diphtheria Tetanus Pertussis Vaccine Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Diphtheria Tetanus Pertussis Vaccine Revenue Market Share by Region (2020-2025)
 Table 23. Global Diphtheria Tetanus Pertussis Vaccine Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Diphtheria Tetanus Pertussis Vaccine Revenue Market Share by Region (2026-2031)
 Table 25. North America Diphtheria Tetanus Pertussis Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Diphtheria Tetanus Pertussis Vaccine Sales by Country (2020-2025) & (K Units)
 Table 27. North America Diphtheria Tetanus Pertussis Vaccine Sales by Country (2026-2031) & (K Units)
 Table 28. North America Diphtheria Tetanus Pertussis Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Diphtheria Tetanus Pertussis Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Diphtheria Tetanus Pertussis Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Diphtheria Tetanus Pertussis Vaccine Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Diphtheria Tetanus Pertussis Vaccine Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Diphtheria Tetanus Pertussis Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Diphtheria Tetanus Pertussis Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Diphtheria Tetanus Pertussis Vaccine Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Diphtheria Tetanus Pertussis Vaccine Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Diphtheria Tetanus Pertussis Vaccine Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Diphtheria Tetanus Pertussis Vaccine Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Diphtheria Tetanus Pertussis Vaccine Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Diphtheria Tetanus Pertussis Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Diphtheria Tetanus Pertussis Vaccine Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Diphtheria Tetanus Pertussis Vaccine Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Diphtheria Tetanus Pertussis Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Diphtheria Tetanus Pertussis Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Diphtheria Tetanus Pertussis Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Diphtheria Tetanus Pertussis Vaccine Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Diphtheria Tetanus Pertussis Vaccine Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Diphtheria Tetanus Pertussis Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Diphtheria Tetanus Pertussis Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Diphtheria Tetanus Pertussis Vaccine Sales (K Units) by Type (2020-2025)
 Table 51. Global Diphtheria Tetanus Pertussis Vaccine Sales (K Units) by Type (2026-2031)
 Table 52. Global Diphtheria Tetanus Pertussis Vaccine Sales Market Share by Type (2020-2025)
 Table 53. Global Diphtheria Tetanus Pertussis Vaccine Sales Market Share by Type (2026-2031)
 Table 54. Global Diphtheria Tetanus Pertussis Vaccine Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Diphtheria Tetanus Pertussis Vaccine Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Diphtheria Tetanus Pertussis Vaccine Revenue Market Share by Type (2020-2025)
 Table 57. Global Diphtheria Tetanus Pertussis Vaccine Revenue Market Share by Type (2026-2031)
 Table 58. Global Diphtheria Tetanus Pertussis Vaccine Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Diphtheria Tetanus Pertussis Vaccine Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Diphtheria Tetanus Pertussis Vaccine Sales (K Units) by Application (2020-2025)
 Table 61. Global Diphtheria Tetanus Pertussis Vaccine Sales (K Units) by Application (2026-2031)
 Table 62. Global Diphtheria Tetanus Pertussis Vaccine Sales Market Share by Application (2020-2025)
 Table 63. Global Diphtheria Tetanus Pertussis Vaccine Sales Market Share by Application (2026-2031)
 Table 64. Global Diphtheria Tetanus Pertussis Vaccine Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Diphtheria Tetanus Pertussis Vaccine Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Diphtheria Tetanus Pertussis Vaccine Revenue Market Share by Application (2020-2025)
 Table 67. Global Diphtheria Tetanus Pertussis Vaccine Revenue Market Share by Application (2026-2031)
 Table 68. Global Diphtheria Tetanus Pertussis Vaccine Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Diphtheria Tetanus Pertussis Vaccine Price (US$/Unit) by Application (2026-2031)
 Table 70. Sanofi Pasteur Company Information
 Table 71. Sanofi Pasteur Description and Business Overview
 Table 72. Sanofi Pasteur Diphtheria Tetanus Pertussis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Sanofi Pasteur Diphtheria Tetanus Pertussis Vaccine Product
 Table 74. Sanofi Pasteur Recent Developments/Updates
 Table 75. GSK Company Information
 Table 76. GSK Description and Business Overview
 Table 77. GSK Diphtheria Tetanus Pertussis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. GSK Diphtheria Tetanus Pertussis Vaccine Product
 Table 79. GSK Recent Developments/Updates
 Table 80. AJ Vaccines Company Information
 Table 81. AJ Vaccines Description and Business Overview
 Table 82. AJ Vaccines Diphtheria Tetanus Pertussis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. AJ Vaccines Diphtheria Tetanus Pertussis Vaccine Product
 Table 84. AJ Vaccines Recent Developments/Updates
 Table 85. KM Biologics (Meiji) Company Information
 Table 86. KM Biologics (Meiji) Description and Business Overview
 Table 87. KM Biologics (Meiji) Diphtheria Tetanus Pertussis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. KM Biologics (Meiji) Diphtheria Tetanus Pertussis Vaccine Product
 Table 89. KM Biologics (Meiji) Recent Developments/Updates
 Table 90. MCM Vaccine Company Information
 Table 91. MCM Vaccine Description and Business Overview
 Table 92. MCM Vaccine Diphtheria Tetanus Pertussis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. MCM Vaccine Diphtheria Tetanus Pertussis Vaccine Product
 Table 94. MCM Vaccine Recent Developments/Updates
 Table 95. Merck Company Information
 Table 96. Merck Description and Business Overview
 Table 97. Merck Diphtheria Tetanus Pertussis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Merck Diphtheria Tetanus Pertussis Vaccine Product
 Table 99. Merck Recent Developments/Updates
 Table 100. MassBiologics Company Information
 Table 101. MassBiologics Description and Business Overview
 Table 102. MassBiologics Diphtheria Tetanus Pertussis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. MassBiologics Diphtheria Tetanus Pertussis Vaccine Product
 Table 104. MassBiologics Recent Developments/Updates
 Table 105. Bionet-Asia Company Information
 Table 106. Bionet-Asia Description and Business Overview
 Table 107. Bionet-Asia Diphtheria Tetanus Pertussis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Bionet-Asia Diphtheria Tetanus Pertussis Vaccine Product
 Table 109. Bionet-Asia Recent Developments/Updates
 Table 110. Amson Vaccines & Pharma Company Information
 Table 111. Amson Vaccines & Pharma Description and Business Overview
 Table 112. Amson Vaccines & Pharma Diphtheria Tetanus Pertussis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Amson Vaccines & Pharma Diphtheria Tetanus Pertussis Vaccine Product
 Table 114. Amson Vaccines & Pharma Recent Developments/Updates
 Table 115. Serum Institute of India Company Information
 Table 116. Serum Institute of India Description and Business Overview
 Table 117. Serum Institute of India Diphtheria Tetanus Pertussis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Serum Institute of India Diphtheria Tetanus Pertussis Vaccine Product
 Table 119. Serum Institute of India Recent Developments/Updates
 Table 120. Panacea Biotec Company Information
 Table 121. Panacea Biotec Description and Business Overview
 Table 122. Panacea Biotec Diphtheria Tetanus Pertussis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Panacea Biotec Diphtheria Tetanus Pertussis Vaccine Product
 Table 124. Panacea Biotec Recent Developments/Updates
 Table 125. BioKangtai Company Information
 Table 126. BioKangtai Description and Business Overview
 Table 127. BioKangtai Diphtheria Tetanus Pertussis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. BioKangtai Diphtheria Tetanus Pertussis Vaccine Product
 Table 129. BioKangtai Recent Developments/Updates
 Table 130. China National Biotec Company Information
 Table 131. China National Biotec Description and Business Overview
 Table 132. China National Biotec Diphtheria Tetanus Pertussis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 133. China National Biotec Diphtheria Tetanus Pertussis Vaccine Product
 Table 134. China National Biotec Recent Developments/Updates
 Table 135. Chengdu Oulin Biological Science&Technology Company Information
 Table 136. Chengdu Oulin Biological Science&Technology Description and Business Overview
 Table 137. Chengdu Oulin Biological Science&Technology Diphtheria Tetanus Pertussis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 138. Chengdu Oulin Biological Science&Technology Diphtheria Tetanus Pertussis Vaccine Product
 Table 139. Chengdu Oulin Biological Science&Technology Recent Developments/Updates
 Table 140. Key Raw Materials Lists
 Table 141. Raw Materials Key Suppliers Lists
 Table 142. Diphtheria Tetanus Pertussis Vaccine Distributors List
 Table 143. Diphtheria Tetanus Pertussis Vaccine Customers List
 Table 144. Diphtheria Tetanus Pertussis Vaccine Market Trends
 Table 145. Diphtheria Tetanus Pertussis Vaccine Market Drivers
 Table 146. Diphtheria Tetanus Pertussis Vaccine Market Challenges
 Table 147. Diphtheria Tetanus Pertussis Vaccine Market Restraints
 Table 148. Research Programs/Design for This Report
 Table 149. Key Data Information from Secondary Sources
 Table 150. Key Data Information from Primary Sources
 Table 151. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Diphtheria Tetanus Pertussis Vaccine
 Figure 2. Global Diphtheria Tetanus Pertussis Vaccine Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Diphtheria Tetanus Pertussis Vaccine Market Share by Type: 2024 & 2031
 Figure 4. DTwP Type Product Picture
 Figure 5. DTaP Type Product Picture
 Figure 6. Global Diphtheria Tetanus Pertussis Vaccine Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Diphtheria Tetanus Pertussis Vaccine Market Share by Application: 2024 & 2031
 Figure 8. Child
 Figure 9. Teenager
 Figure 10. Aldult
 Figure 11. Global Diphtheria Tetanus Pertussis Vaccine Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Diphtheria Tetanus Pertussis Vaccine Market Size (2020-2031) & (US$ Million)
 Figure 13. Global Diphtheria Tetanus Pertussis Vaccine Sales (2020-2031) & (K Units)
 Figure 14. Global Diphtheria Tetanus Pertussis Vaccine Average Price (US$/Unit) & (2020-2031)
 Figure 15. Diphtheria Tetanus Pertussis Vaccine Report Years Considered
 Figure 16. Diphtheria Tetanus Pertussis Vaccine Sales Share by Manufacturers in 2024
 Figure 17. Global Diphtheria Tetanus Pertussis Vaccine Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest Diphtheria Tetanus Pertussis Vaccine Players: Market Share by Revenue in Diphtheria Tetanus Pertussis Vaccine in 2024
 Figure 19. Diphtheria Tetanus Pertussis Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global Diphtheria Tetanus Pertussis Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America Diphtheria Tetanus Pertussis Vaccine Sales Market Share by Country (2020-2031)
 Figure 22. North America Diphtheria Tetanus Pertussis Vaccine Revenue Market Share by Country (2020-2031)
 Figure 23. United States Diphtheria Tetanus Pertussis Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada Diphtheria Tetanus Pertussis Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe Diphtheria Tetanus Pertussis Vaccine Sales Market Share by Country (2020-2031)
 Figure 26. Europe Diphtheria Tetanus Pertussis Vaccine Revenue Market Share by Country (2020-2031)
 Figure 27. Germany Diphtheria Tetanus Pertussis Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France Diphtheria Tetanus Pertussis Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. Diphtheria Tetanus Pertussis Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy Diphtheria Tetanus Pertussis Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia Diphtheria Tetanus Pertussis Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific Diphtheria Tetanus Pertussis Vaccine Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific Diphtheria Tetanus Pertussis Vaccine Revenue Market Share by Region (2020-2031)
 Figure 34. China Diphtheria Tetanus Pertussis Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan Diphtheria Tetanus Pertussis Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea Diphtheria Tetanus Pertussis Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India Diphtheria Tetanus Pertussis Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia Diphtheria Tetanus Pertussis Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. China Taiwan Diphtheria Tetanus Pertussis Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Indonesia Diphtheria Tetanus Pertussis Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Thailand Diphtheria Tetanus Pertussis Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Malaysia Diphtheria Tetanus Pertussis Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Latin America Diphtheria Tetanus Pertussis Vaccine Sales Market Share by Country (2020-2031)
 Figure 44. Latin America Diphtheria Tetanus Pertussis Vaccine Revenue Market Share by Country (2020-2031)
 Figure 45. Mexico Diphtheria Tetanus Pertussis Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Brazil Diphtheria Tetanus Pertussis Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Argentina Diphtheria Tetanus Pertussis Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Middle East and Africa Diphtheria Tetanus Pertussis Vaccine Sales Market Share by Country (2020-2031)
 Figure 49. Middle East and Africa Diphtheria Tetanus Pertussis Vaccine Revenue Market Share by Country (2020-2031)
 Figure 50. Turkey Diphtheria Tetanus Pertussis Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Saudi Arabia Diphtheria Tetanus Pertussis Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. UAE Diphtheria Tetanus Pertussis Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Global Sales Market Share of Diphtheria Tetanus Pertussis Vaccine by Type (2020-2031)
 Figure 54. Global Revenue Market Share of Diphtheria Tetanus Pertussis Vaccine by Type (2020-2031)
 Figure 55. Global Diphtheria Tetanus Pertussis Vaccine Price (US$/Unit) by Type (2020-2031)
 Figure 56. Global Sales Market Share of Diphtheria Tetanus Pertussis Vaccine by Application (2020-2031)
 Figure 57. Global Revenue Market Share of Diphtheria Tetanus Pertussis Vaccine by Application (2020-2031)
 Figure 58. Global Diphtheria Tetanus Pertussis Vaccine Price (US$/Unit) by Application (2020-2031)
 Figure 59. Diphtheria Tetanus Pertussis Vaccine Value Chain
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS

Global Diphtheria Tetanus and Pertussis DTaP Vaccine Market Research Report 2024
Global TD Vaccine Market Research Report 2025
Global DPT Series Vaccine Market Research Report 2024
Global Diphtheria Vaccines Market Research Report 2024
Global Adsorbed DTP Vaccine Market Research Report 2024
Global Tetanus Toxoid Vaccine Market Research Report 2024
Global Adsorption of DTP Combination Vaccine Market Research Report 2025
Diphtheria Tetanus Pertussis Mix Vaccine for Children Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Pertussis Vaccination Market Research Report 2025
Global DPT Vaccines Market Research Report 2025
Global DPT Vaccination Market Research Report 2025
Global DTaP and Tdap Vaccines Market Insights Forecast to 2030
Diphtheria Tetanus and Acellular Pertussis Combined Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Component DTP Vaccine Market Research Report 2024
Global Acellular DTP Vaccine Market Research Report 2024
Global Tetanus and Diphtheria Toxoids Adsorbed Market Research Report 2025
Global DT Based Combined Vaccines Market Research Report 2024
Global Diphtheria Toxoid Market Research Report 2025
Global Pertussis Treatment Market Research Report 2024
Global Pertussis Vaccine Market Insights Forecast to 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions